AP
AZN icon

Atwood & Palmer’s AstraZeneca AZN Stock Holding History

Atwood & Palmer’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$19.7K – 498
2026
Q1 		$19.7K Hold
100
– – ﹤0.01% 323
2025
Q4 		$18.4K Hold
100
– – ﹤0.01% 328
2025
Q3 		$15.3K Hold
100
– – ﹤0.01% 352
2025
Q2 		$14K Hold
100
– – ﹤0.01% 355
2025
Q1 		$14.7K Hold
100
– – ﹤0.01% 308
2024
Q4 		$13.1K Hold
100
– – ﹤0.01% 318
2024
Q3 		$15.6K Hold
100
– – ﹤0.01% 304
2024
Q2 		$15.6K Hold
100
– – ﹤0.01% 319
2024
Q1 		$13.6K Hold
100
– – ﹤0.01% 294
2023
Q4 		$13.5K Hold
100
– – ﹤0.01% 301
2023
Q3 		$13.5K Hold
100
– – ﹤0.01% 292
2023
Q2 		$14.3K Hold
100
– – ﹤0.01% 297
2023
Q1 		$13.9K Hold
100
– – ﹤0.01% 285
2022
Q4 		$13.6K Hold
100
– – ﹤0.01% 307
2022
Q3 		$11K Hold
100
– – ﹤0.01% 300
2022
Q2 		$13K Hold
100
– – ﹤0.01% 313
2022
Q1 		$13K Hold
100
– – ﹤0.01% 349
2021
Q4 		$12K Hold
100
– – ﹤0.01% 359
2021
Q3 		$12K Hold
100
– – ﹤0.01% 343
2021
Q2 		$12K Sell
100
-50
-33% -$5.49K ﹤0.01% 319
2021
Q1 		$15K Hold
150
– – ﹤0.01% 317
2020
Q4 		$15K Hold
150
– – ﹤0.01% 293
2020
Q3 		$16K Buy
+150
New +$16.7K ﹤0.01% 241
2014
Q4 		– Sell
-30
Closed -$2K – 383
2014
Q3 		$2K Hold
30
– – ﹤0.01% 363
2014
Q2 		$2K Buy
+30
New +$2.17K ﹤0.01% 313

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Atwood & Palmer's AZN Position: Q2 2026 in Review

Atwood & Palmer sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 100 shares — an estimated $19.7K sold.

Atwood & Palmer first reported a position in AZN in Q2 2014 and held it in 25 quarters. The position peaked at $19.7K in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Atwood & Palmer reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Atwood & Palmer sold 100 AstraZeneca shares in Q2 2026, an estimated $19.7K.
  • Atwood & Palmer first reported a position in AstraZeneca in Q2 2014 and held it in 25 quarters.
  • Atwood & Palmer's AstraZeneca position peaked at $19.7K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.